To recover your password please fill in your email address
Please fill in below form to create an account with us
A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours (ANZUP1302).
See ANZCTR for full trial details >
To determine if accelerated BEP (Bleomycin, Etoposide and Cisplatin) is superior to standard BEP as first-line chemotherapy for intermediate and poor-risk metastatic germ cell tumours.
Men ≤ 16 years but 45 years ≥ with metastatic germ cell tumours (non-seminoma and seminoma) or intermediate or poor prognostic category with adequate bone marrow, hepatic and renal function.
Australian Lead Group:
A/Prof Peter Grimison